​

Surmodics (SRDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SRDX Stock Forecast

Surmodics (SRDX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $39.50, with a high of $43.00 and a low of $36.00. This represents a 43.85% increase from the last price of $27.46.

$25 $29 $33 $37 $41 $45 High: $43 Avg: $39.5 Low: $36 Last Closed Price: $27.46

SRDX Stock Rating

Surmodics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 1 Strong Buy (14.29%), 3 Buy (42.86%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 3 1 Strong Sell Sell Hold Buy Strong Buy

SRDX Price Target Upside V Benchmarks

TypeNameUpside
StockSurmodics43.85%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks18.84%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$27.46$27.46$27.46
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25--2--2
Sep, 25--2--2
Aug, 25--2--2
Jul, 25--2--2
Jun, 25-12--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 29, 2024Brooks O'NeilLake Street$43.00$42.072.21%56.59%
Jun 13, 2023Downgrades StockNeedham$36.00$26.3536.62%31.10%
Apr 28, 2022Needham$46.00$40.0514.86%67.52%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2025Lake StreetHoldBuyupgrade
May 30, 2024NeedhamUnderperformUnderperformhold
May 29, 2024Lake StreetHolddowngrade
Feb 13, 2023NeedhamBuyHolddowngrade
Apr 28, 2022NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$0.31$-1.96$-0.11$-0.82--
Avg Forecast$0.21$-1.48$-0.26$-0.56$-0.24$0.28
High Forecast$0.21$-1.18$-0.25$-0.54$-0.20$0.29
Low Forecast$0.20$-1.78$-0.27$-0.58$-0.27$0.27
Surprise %47.62%32.43%-57.69%46.43%--

Revenue Forecast

$95M $109M $123M $137M $151M $165M Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$105.14M$99.95M$132.58M$126.08M--
Avg Forecast$104.15M$133.10M$130.86M$123.25M$140.60M$159.83M
High Forecast$105.49M$159.72M$131.08M$126.56M$141.70M$160.71M
Low Forecast$101.87M$106.48M$130.59M$120.01M$139.50M$158.94M
Surprise %0.95%-24.90%1.32%2.30%--

Net Income Forecast

$-30M $-22M $-14M $-6M $2M $10M Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$4.24M$-27.27M$-1.54M$-11.54M--
Avg Forecast$2.16M$-13.12M$5.52M$-7.88M$-3.31M$3.96M
High Forecast$5.01M$-10.50M$6.63M$-7.61M$-2.86M$4.15M
Low Forecast$-699.65K$-15.75M$4.42M$-8.15M$-3.75M$3.78M
Surprise %96.58%107.86%-127.82%46.44%--

SRDX Forecast FAQ

Is Surmodics stock a buy?

Surmodics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Surmodics is a favorable investment for most analysts.

What is Surmodics's price target?

Surmodics's price target, set by 7 Wall Street analysts, averages $39.5 over the next 12 months. The price target range spans from $36 at the low end to $43 at the high end, suggesting a potential 43.85% change from the previous closing price of $27.46.

How does Surmodics stock forecast compare to its benchmarks?

Surmodics's stock forecast shows a 43.85% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (18.84%).

What is the breakdown of analyst ratings for Surmodics over the past three months?

  • October 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Surmodics’s EPS forecast?

Surmodics's average annual EPS forecast for its fiscal year ending in September 2025 is $-0.24, marking a -70.73% decrease from the reported $-0.82 in 2024. Estimates for the following years are.

What is Surmodics’s revenue forecast?

Surmodics's average annual revenue forecast for its fiscal year ending in September 2025 is $140.6M, reflecting a 11.52% increase from the reported $126.08M in 2024. The forecast for.

What is Surmodics’s net income forecast?

Surmodics's net income forecast for the fiscal year ending in September 2025 stands at $-3.307M, representing a -71.35% decrease from the reported $-11.542M in 2024. Projections indicate .